4Powell JD,Horton MR.Threat matrix:low molecular weight hyaluronan (HA) as a danger signal.Immunol Res,2005,31:207-218.
5Haylock DN,Nilsson SK.The role of hyaluronic acid in hemopoietic stem cell biology.Regen Med,2006,1:437-445.
6Bourguignon LY.Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.Semin Cancer Biol,2008,18:251-259.
7Maxwell CA,McCarthy J,Turley E.Cell-surface and mitotic-spindle RHAMM:moonlighting or dual oncogenic functions? J Cell Sci,2008,121:925-932.
8Nagel S,Hirschmann P,Dimhofer S,et al.Coexpression of CD44 variant isofims and receptor fir hyaluronic acid-mediated motility (RHAMM,CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphoma.Exp Hematol,2010,38:38-45.
9Greiner J,Schmitt A,Giannopoulos K,et al.High-dose RHAMM-R3 peptide vaccinatian for patents with acute myeloid leukemia,myelodysplastic syndrome and multiple myeloma.Haematologica,2010,95:1191-1197.
10Giannopoulos K,Dmoszynska A,Kowal M,et al.Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD+8 T-cell responses in patients with chronic lymphocytic leukemia.Leukemia,2010,24:798-805.
